PMID: 8615424May 1, 1996Paper

Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease

The American Journal of Psychiatry
G J HarrisP F Renshaw

Abstract

The purpose of this study was to investigate the potential effectiveness of dynamic susceptibility contrast magnetic resonance imaging (MRI) to discriminate elderly patients with Alzheimer's disease from normal matched comparison subjects. Images of regional cerebral blood volume (CBV) were generated from echo-planar MRI with the dynamic susceptibility contrast method in 13 Alzheimer's disease patients and 13 comparison subjects group-matched on age and gender. Temporoparietal cerebral blood volume, expressed as a percentage of the cerebellum value, was reduced 17% bilaterally in the patients with Alzheimer's disease. Blood volume in sensorimotor regions was reduced only 8.5% in the patients. Discriminant function analysis based on left and right temporoparietal measures correctly classified 88.5% of the subjects as patients or comparison subjects. Temporoparietal CBV was reduced even in mildly affected Alzheimer's disease patients (Mini-Mental State scores > 24). Dynamic susceptibility contrast MRI of regional CBV is promising as a nonradioactive, potentially lower-cost alternative to other functional neuroimaging methods for evaluating Alzheimer's disease.

Citations

Jun 14, 2013·Journal of Neurointerventional Surgery·Zi-Jun HeDa-Ming Wang
Dec 14, 2002·Lancet·Karen Ritchie, Simon Lovestone
Jan 15, 1999·Magnetic Resonance Imaging· Frederick B deBP F Renshaw
Jun 21, 2011·Cardiovascular Psychiatry and Neurology·Valerie C AndersonWilliam D Rooney
Jan 1, 2009·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Erez NossekZvi Ram
Feb 4, 2003·Radiology·Jeffrey R PetrellaP Murali Doraiswamy
Nov 3, 2016·American Journal of Veterinary Research·Antje HartmannMartin J Schmidt
Oct 29, 2005·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Hanzhang LuJoseph A Helpern
Jul 21, 1999·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·F CalamanteR Turner
Sep 21, 2001·Journal of Geriatric Psychiatry and Neurology·Y Y HsuM W Weiner
Jun 17, 1999·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·O SpeckT Ernst
Oct 16, 2018·Journal of Magnetic Resonance Imaging : JMRI·Shaozhen YanJie Lu
Apr 14, 2009·Topics in Magnetic Resonance Imaging : TMRI·Jean Théberge
Nov 8, 2006·Topics in Magnetic Resonance Imaging : TMRI·Valerie C AndersonJeffrey A Kaye
May 4, 2007·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Susanne G MuellerLaurel Beckett
Nov 16, 2010·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Wei ChenKenneth Rockwood
Mar 12, 2013·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Pelin Aksit CirisRobert Todd Constable
May 9, 2000·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·R WirestamF Ståhlberg
Apr 29, 2021·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Lirong YanHosung Kim
Feb 18, 2020·Neuro-degenerative Diseases·Jan Klohs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.